Oncogenic Y‐box binding protein‐1 as an effective therapeutic target in drug‐resistant cancer
Author:
Affiliation:
1. Cancer Translational Research CenterSt. Mary's Institute of Health Sciences Kurume Japan
2. Department of Pharmaceutical OncologyGraduate School of Pharmaceutical SciencesKyushu University Fukuoka Japan
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14006
Reference58 articles.
1. Overcoming drug resistance to receptor tyrosine kinase inhibitors: Learning from lung cancer
2. Revisiting the role of ABC transporters in multidrug-resistant cancer
3. DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.
4. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
5. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer;Cancer Letters;2024-10
2. Proteomic insights into breast cancer response to brain cell-secreted factors;Scientific Reports;2024-08-21
3. Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis;Oncogene;2024-08-18
4. SETD8 inhibits apoptosis and ferroptosis of Ewing’s sarcoma through YBX1/RAC3 axis;Cell Death & Disease;2024-07-10
5. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1;Life Sciences;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3